AR012014A1 - Composiciones para tratamiento de un dia de enfermedades mediadas por ciclooxigenasa-2 - Google Patents
Composiciones para tratamiento de un dia de enfermedades mediadas por ciclooxigenasa-2Info
- Publication number
- AR012014A1 AR012014A1 ARP970102021A ARP970102021A AR012014A1 AR 012014 A1 AR012014 A1 AR 012014A1 AR P970102021 A ARP970102021 A AR P970102021A AR P970102021 A ARP970102021 A AR P970102021A AR 012014 A1 AR012014 A1 AR 012014A1
- Authority
- AR
- Argentina
- Prior art keywords
- cyclooxygenase
- treatment
- compound
- directed
- mediated diseases
- Prior art date
Links
- 108010037462 Cyclooxygenase 2 Proteins 0.000 title abstract 6
- 201000010099 disease Diseases 0.000 title abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 5
- 230000001404 mediated effect Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 102000010907 Cyclooxygenase 2 Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 6
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 108010037464 Cyclooxygenase 1 Proteins 0.000 abstract 1
- 229940093444 Cyclooxygenase 2 inhibitor Drugs 0.000 abstract 1
- 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 abstract 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Esta invencion está dirigida a composiciones farmacéuticas para el tratamiento de enfermedades mediadas por ciclooxigenasa-2, dicha composicionsiendo apropiada para una administracion diaria, dicha composicion comprende un compuestoinhib idor de ciclooxigenasa-2 caracterizado por alta potencia,una larga vida media y un alto grado de especificidad para inhibir ciclooxigenasa-2 en preferencia a ciclooxigenasa-1. Tal compuesto esejemplificado por 3-fenil-4-(4-metilsulfonil) fenil)-2-(5H)-furanona. En un aspecto, esta invencion es dirigida a las composiciones farmacéuticas parael tratamiento de enfermedades mediadas por ciclooxigenasa-2, dicha composicion siendo apropiada para una administraciondiaria, dicha compos icion comprende de5 a 125 mg del compuesto arriba mencionado. La invencion es también dirigida a un método para el tratamiento de enfermedades mediadas por ciclooxigenasa-2que comprende una administracion oral diaria de 5 a125 mg del compuesto ar riba mencionado. La invencion es también dirigida al uso del mencionado compuestoen la manufactura de un medicamento que contiene 5 a 125 mg de dicho compuesto para una administracion diaria para el tratamiento deenfermedades mediadas porciclooxige nasa-2.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1787896P | 1996-05-17 | 1996-05-17 | |
| GBGB9612063.9A GB9612063D0 (en) | 1996-06-10 | 1996-06-10 | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012014A1 true AR012014A1 (es) | 2000-09-27 |
Family
ID=26309472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102021A AR012014A1 (es) | 1996-05-17 | 1997-05-14 | Composiciones para tratamiento de un dia de enfermedades mediadas por ciclooxigenasa-2 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6063811A (es) |
| EP (1) | EP0910368A1 (es) |
| JP (1) | JPH11512754A (es) |
| KR (1) | KR100373622B1 (es) |
| CN (1) | CN1140267C (es) |
| AR (1) | AR012014A1 (es) |
| AU (1) | AU3004997A (es) |
| BG (1) | BG103000A (es) |
| BR (1) | BR9709097A (es) |
| CA (1) | CA2254061C (es) |
| CO (1) | CO5050370A1 (es) |
| CZ (1) | CZ291463B6 (es) |
| DZ (1) | DZ2200A1 (es) |
| EA (1) | EA001596B1 (es) |
| EE (1) | EE03746B1 (es) |
| HK (1) | HK1021623A1 (es) |
| HR (1) | HRP970262A2 (es) |
| HU (1) | HUP9902889A3 (es) |
| ID (1) | ID16921A (es) |
| IL (1) | IL126899A (es) |
| IS (1) | IS4891A (es) |
| MY (1) | MY116201A (es) |
| NO (1) | NO985342L (es) |
| NZ (1) | NZ332670A (es) |
| PE (1) | PE66998A1 (es) |
| PL (1) | PL188649B1 (es) |
| SK (1) | SK284330B6 (es) |
| TR (1) | TR199802345T2 (es) |
| WO (1) | WO1997044028A1 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
| EP1061908A4 (en) * | 1998-03-13 | 2007-01-24 | Merck & Co Inc | COMBINATION THERAPY AND COMPOSITION FOR ACUTE CORONARY MIXING SYNDROME AND ASSOCIATED CONDITIONS |
| SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| CO5190664A1 (es) | 1999-06-30 | 2002-08-29 | Pfizer Prod Inc | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 |
| GB9920558D0 (en) * | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
| MXPA02006150A (es) * | 1999-12-22 | 2004-09-06 | Pharmacia Corp | Formulaciones de liberacion sostenida de un inhibidor de ciclooxigenasa-2. |
| US6924303B2 (en) | 2000-06-13 | 2005-08-02 | Wyeth | Analgesic and anti-inflammatory compositions containing COX-2 inhibitors |
| CN1638739A (zh) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | 治疗成瘾性障碍的化合物 |
| DK1309315T3 (da) * | 2000-08-18 | 2006-10-09 | Pharmacia Corp | Hurtigt disintegrerende oral valdecoxib-formulering |
| US8680081B2 (en) * | 2000-08-29 | 2014-03-25 | Peter Van Patten | Prophylactic treatment of migraine |
| AR030630A1 (es) * | 2000-09-11 | 2003-08-27 | Novartis Ag | Composiciones farmaceuticas |
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| US20040132780A1 (en) * | 2001-05-04 | 2004-07-08 | Allen Christopher P. | Method and compositions for treating migraines |
| AR036312A1 (es) * | 2001-08-31 | 2004-08-25 | Novartis Ag | Composicion farmaceutica |
| KR20040044990A (ko) * | 2001-09-26 | 2004-05-31 | 파마시아 코포레이션 | 구강내 붕해성 발데콕시브 조성물 |
| CN1602187A (zh) * | 2001-10-10 | 2005-03-30 | 法马西亚公司 | 通过喷雾干燥法制备的口内崩解的伐地考昔组合物 |
| EP1492520A1 (en) * | 2002-03-07 | 2005-01-05 | Novartis AG | Pharmaceutical compositions |
| ES2213485B1 (es) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | Derivados de la 2-fenilpiran-4-ona. |
| ES2214129B1 (es) * | 2003-02-13 | 2005-12-01 | Almirall Prodesfarma, S.A. | 3-fenilfuran-2-onas. |
| PL1534305T3 (pl) | 2003-05-07 | 2007-03-30 | Osteologix As | Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie |
| TR200301552A1 (tr) * | 2003-09-18 | 2005-10-21 | Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Rofekoksib' in yeni oral farmakolojik formülasyonları. |
| CA2676413A1 (en) * | 2007-01-19 | 2008-07-31 | Mallinckrodt Inc. | Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| WO2020106522A1 (en) | 2018-11-21 | 2020-05-28 | Tremeau Pharmaceuticals, Inc. | Purified forms of rofecoxib, methods of manufacture and use |
| WO2020210373A1 (en) * | 2019-04-09 | 2020-10-15 | Tremeau Pharmaceuticals, Inc. | Treatment of viral hemorrhagic fevers with etoricoxib |
| US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
| US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| WO1995018799A1 (en) * | 1994-01-10 | 1995-07-13 | Merck Frosst Canada Inc. | Phenyl heterocycles as cox-2 inhibitors |
-
1997
- 1997-05-13 CN CNB971963150A patent/CN1140267C/zh not_active Expired - Fee Related
- 1997-05-13 WO PCT/US1997/008041 patent/WO1997044028A1/en not_active Application Discontinuation
- 1997-05-13 HU HU9902889A patent/HUP9902889A3/hu unknown
- 1997-05-13 EA EA199801017A patent/EA001596B1/ru not_active IP Right Cessation
- 1997-05-13 TR TR1998/02345T patent/TR199802345T2/xx unknown
- 1997-05-13 IL IL12689997A patent/IL126899A/en not_active IP Right Cessation
- 1997-05-13 CZ CZ19983738A patent/CZ291463B6/cs not_active IP Right Cessation
- 1997-05-13 EE EE9800393A patent/EE03746B1/xx not_active IP Right Cessation
- 1997-05-13 KR KR10-1998-0709239A patent/KR100373622B1/ko not_active IP Right Cessation
- 1997-05-13 JP JP9542486A patent/JPH11512754A/ja active Pending
- 1997-05-13 BR BR9709097A patent/BR9709097A/pt not_active IP Right Cessation
- 1997-05-13 CA CA002254061A patent/CA2254061C/en not_active Expired - Fee Related
- 1997-05-13 EP EP97924688A patent/EP0910368A1/en not_active Withdrawn
- 1997-05-13 SK SK1567-98A patent/SK284330B6/sk unknown
- 1997-05-13 US US09/180,647 patent/US6063811A/en not_active Expired - Lifetime
- 1997-05-13 NZ NZ332670A patent/NZ332670A/xx unknown
- 1997-05-13 AU AU30049/97A patent/AU3004997A/en not_active Abandoned
- 1997-05-14 DZ DZ970087A patent/DZ2200A1/fr active
- 1997-05-14 AR ARP970102021A patent/AR012014A1/es unknown
- 1997-05-15 PE PE1997000379A patent/PE66998A1/es not_active Application Discontinuation
- 1997-05-16 ID IDP971640A patent/ID16921A/id unknown
- 1997-05-16 CO CO97026568A patent/CO5050370A1/es unknown
- 1997-05-16 MY MYPI97002138A patent/MY116201A/en unknown
- 1997-05-16 HR HR9612063.9A patent/HRP970262A2/xx not_active Application Discontinuation
-
1998
- 1998-11-10 IS IS4891A patent/IS4891A/is unknown
- 1998-11-16 NO NO985342A patent/NO985342L/no not_active Application Discontinuation
- 1998-12-08 BG BG103000A patent/BG103000A/xx unknown
-
1999
- 1999-01-11 PL PL97329940A patent/PL188649B1/pl not_active IP Right Cessation
-
2000
- 2000-02-02 HK HK00100645A patent/HK1021623A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012014A1 (es) | Composiciones para tratamiento de un dia de enfermedades mediadas por ciclooxigenasa-2 | |
| DE69637096D1 (de) | Stabile n-propargyl-1-aminoindan enthaltende zusammensetzungen | |
| DK0828724T3 (da) | 5-oxygenerede diaryl-2-(5H)-furanoner som COX-2-inhibitorer | |
| DK0688214T3 (da) | Fremgangsmåder til inhibering af knogletab med 3,4-diarylchroman | |
| CO5180579A1 (es) | Composicion oral solida que comprende levidopa, carbidopa y entacapone | |
| ATE306261T1 (de) | Antithrombosemittel | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
| HUP0100043A2 (hu) | Savérzékeny hatóanyagot tartalmazó új gyógyszerforma | |
| DK2295052T3 (da) | Anvendelse af ritonavir til forbedring af farmakokinetikken af lægemidler, der metaboliseres af cytochrom P450 | |
| AU2001289820A1 (en) | Novel pharmaceutical composition for administering n-0923 | |
| IS8807A (is) | Notkun á daptómýsíni og lyfjasamsetningar sem innihalda það | |
| PT948527E (pt) | Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem | |
| ATE234282T1 (de) | Polymorphe verbindungen | |
| AR045572A1 (es) | Una combinacion que comprende n-(3-metoxi-5-metilpirazin-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil-3-sulfonamida y un analogo lhrh y/o un bifosfonato | |
| GT199700037A (es) | Composiciones farmaceuticas para el tratamiento de la rinitis | |
| BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
| FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
| CR5926A (es) | Combinaciones de estatina-eter carboxialquilico | |
| DK0701449T3 (da) | Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac | |
| DE69819539D1 (de) | Antithrombotische mittel | |
| ATE81775T1 (de) | Pharmazeutische zusammensetzungen. | |
| BR0204889A (pt) | Kit para a redução de dor | |
| ECSP972123A (es) | Composiciones para un tratamiento de una sola vez de enfermedades en que intervienen la ciclooxigenasa- 2 - | |
| DK0627916T3 (da) | Farmaceutisk præparat, anvendeligt som analgetikum og indeholdende (R)-2-(3-benzoylphenyl)propionsyre |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |